Virtual colonoscopy is likely to perform well in the American College of Radiology Imaging Network Trial, but the result could be a $2 billion boost in national colon cancer screening costs, according to a presentation Monday at the Sixth Annual Virtual Colonoscopy Symposium in Boston.
Virtual colonoscopy is likely to perform well in the American College of Radiology Imaging Network Trial, but the result could be a $2 billion boost in national colon cancer screening costs, according to a presentation Monday at the Sixth Annual Virtual Colonoscopy Symposium in Boston.
Dr. Jay Heiken, director of abdominal imaging at Washington University in St. Louis, predicted that when the ACRIN 6664 National CT Colonoscopy Trial is completed, virtual colonoscopy will have achieved a sensitivity of between 75% and 85% for polyps greater than 10 mm.
"Given such results, we will be able to establish virtual colonoscopy as a legitimate screening test for colorectal cancer," Heiken said.
With a goal of 2300 to 2600 participants, the ACRIN 6664 trial now has 15 institutions on board and is expected to report results within a year, said Dr. C. Daniel Johnson, a professor of radiology at the Mayo Clinic in Rochester, MN.
If virtual colonoscopy achieves good results, public demand for the test would increase, but the mood of third-party payers could be panic, Heiken said.
He gave a rough economic analysis based on allowable reimbursement by Medicare in Missouri predicting what would happen if virtual colonoscopy were added to the colon cancer screening roster. He cited the costs of the various screening methods:
Broken down to a yearly cost per patient, costs could range from $46 for the fecal occult blood test to $111 for virtual colonoscopy, according to Heiken.
If half of patients switch from an alternative screening method to virtual colonoscopy and patient compliance does not improve, annual screening costs would increase by $700 million, Heiken said. If another 25% of those who would never have gotten screened decide to undergo virtual colonoscopy, the costs would increase by $1.5 billion. If the compliance percentage jumps to 50%, the costs would move up to $2 billion.
This analysis did not include ancillary costs, including follow-up interventions, which could increase these totals further, Heiken said. Ideally, a more comprehensive analysis would also include potential savings introduced by moving to virtual colonoscopy screening. These could be significant considering the astronomical costs of treating patients who have cancer.
For more information from the online Diagnostic Imaging archives:
CT colonography screening trial seeks definitive answers
Large CT colonography trial opens with mixed reactions
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.